MedPath

Delayed Response to Antipsychotic Medication in Psychosis

Not Applicable
Completed
Conditions
Health Condition 1: null- Non Affective Psychosis
Registration Number
CTRI/2017/11/010391
Lead Sponsor
Goverment Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Patient should meet the following psychopathology severity criteria at the time of inclusion into the study

1.total score extracted from Positive and Negative Syndrome Scale should be atleast 45

2. A score of atleast 4 [moderate] on at least 2 of following BPRS items: conceptual disorganization, suspiciousness, hallucinatory behavior and unusual thought content

3.Patient who are either drug naïve or who had relapsed in preceding 2 weeks requiring change in medications.

Exclusion Criteria

1.Patient with history of inadequate response to risperidone or olanzapine in the past.

2.Patient with history of allergic reaction to risperidone or olanzpine

3.History of use of risperidone or olanzapine with in past 30 days before the study enrolment.

4.Acute, serious or unstable co-morbid medical condition

5.Schizo-affective disorder

6.Active substance dependence except nicotine and caffeine

7.Pregnant and lactating women

8.Treatment resistant schizophrenia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Identify the early responder and non responder <br/ ><br>2.the response rate amongst the early non-responders after either continuing on the same antipsychotic or being switched over to another atypical antipsychoticTimepoint: 1t week,2nd week,4th week,6th week,8th week.
Secondary Outcome Measures
NameTimeMethod
20% Reduction in the illness severity on PANSS.Timepoint: 2nd week
© Copyright 2025. All Rights Reserved by MedPath